跳至主要内容
临床试验/CTRI/2023/03/050760
CTRI/2023/03/050760已完成2 期

An Open Label Non-comparative Clinical Trial of Amalaki Rasayana and Cap. Max HB in the management of ‘Sannipataja Pandu Roga’ W.S.R. to Sickle Cell Anaemia

Central Council for Research in Ayurvedic Sciences (CCRAS)0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients between 18-50 yrs. of age, and regular diet habit.
  • 2.Patients will be selected from Pathology laboratory of Roganidan and O.P.D. & I.P.D. of Kayachikitsa department of the institute.
  • 3.Patients Having Hb 07-10 g/dl with moderate Anemia..
  • 4.Patients with confirm Positive sickling test with Type: HbAS or HbSS and presenting sign & symptoms of Sickle cell Anemia.
  • 5.Patients willing to participate in clinical trial.

排除标准

  • 1.Patients who are pregnant and Lactating mother.
  • 2.Patient Severe illness like Tuberculosis, Cancer, Cirrhosis of liver, aplastic anaemia etc. also be excluded.
  • 3.Patients who will not come for regular follow up.

研究者

发起方
Central Council for Research in Ayurvedic Sciences (CCRAS)

相似试验